Financhill
Back

Ionis Pharmaceuticals 10K Form

Buy
53

IONS
Ionis Pharmaceuticals

Last Price:
44.39
Seasonality Move:
-3.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive IONS News And Ratings

See the #1 stock for the next 7 days that we like better than IONS

IONS Financial Statistics

Sales & Book Value

Annual Sales: $587.37M
Cash Flow: $-112.26M
Price / Cash Flow: 0
Annual Sales: $2.20
Price / Book: 20.2

Profitability

EPS (TTM): -2.87000
Net Income (TTM): $-409.45M
Gross Margin: $573.25M
Return on Equity: -85.39%
Return on Assets: -14.89%

Ionis Pharmaceuticals Earnings Forecast

Key Ionis Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 33 years for IONS is 97.60%.
  • The Selling, General & Administrative Expenses for IONS have been equal to 25.59% of Gross Profit Margin.
  • The Research & Development expenses have been 141.84% of Revenue.
  • The Interest Expense is -1.04% of Operating Income.
  • The Net Earning history of IONS is -45.92% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 16 years.

Ionis Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: IONS
CUSIP: 462222
Website: ionispharma.com

Debt

Debt-to-Equity Ratio: 4.06
Current Ratio: 6.39
Quick Ratio: 5.88

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

IONS Technical Analysis vs Fundamental Analysis

Buy
53
Ionis Pharmaceuticals (IONS) is a Buy

Is Ionis Pharmaceuticals a Buy or a Sell?